CN Patent

CN105407896B — 缓释的地塞米松在白内障手术后的炎症中的应用

Assigned to Icon Bioscience Inc · Expires 2019-08-27 · 7y expired

What this patent protects

本实施方式提供了在柠檬酸酯中地塞米松的短期缓释液体制剂的治疗方案和应用，其中小剂型单次给药到眼前房中，提供了用于白内障手术后的抗炎治疗。

USPTO Abstract

本实施方式提供了在柠檬酸酯中地塞米松的短期缓释液体制剂的治疗方案和应用，其中小剂型单次给药到眼前房中，提供了用于白内障手术后的抗炎治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN105407896B
Jurisdiction
CN
Classification
—
Expires
2019-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Icon Bioscience Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.